What this is
- How it works
- How it works isn't classified yet
- Tested for
- Canities, Grey Hair
- Main trialPhase 1/2
- “Clinical Study to Assess the Safety and Efficacy of CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)”In the company’s words, NCT07166354 on ClinicalTrials.gov
Coming up1
- 15 Oct 2027Phase 1/2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Not yet recruiting | 15 Oct 2027 | Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026